{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:17:16Z","timestamp":1794503836166,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hereditary Spastic Paraplegia (HSP) is a rare genetic neurological disorder that causes progressive spasticity and weakness in the lower limbs. This study aims to describe the prevalence and incidence of HSP and examine common mental health outcomes (depression and anxiety) in HSP patients in England and Northern Ireland.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective cohort study used CPRD Aurum primary care data from 1 January 2000 to 31 December 2021. Annual cross-sectional and cohort studies were conducted for yearly prevalence and incidence of HSP. Common mental health outcomes were examined with a 1:4 matched cohort (age+\/\u22121\u00a0year, sex, general practice). Descriptive analysis and logistic regression assessed the characteristics of the HSP cohort and baseline depression and anxiety. Cox regression assessed the hazard of new diagnosis of depression and anxiety.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The overall cohort included 31,302,579 patients; the matched cohort included 1455 HSP patients and 5726 control non-HSP patients. Patients who were male (adjusted odds ratio [aOR] 1.45, 95% CI: 1.31\u20131.61), of White ethnicity (lower odds in all other ethnicity) and from most other geographical areas compared to London had higher odds of a HSP diagnosis, with the highest odds for North East (aOR 3.51, 95% CI: 2.73\u20134.50) and Northern Ireland (aOR 3.15, 95% CI: 1.62\u20136.16). HSP prevalence increased from 2.83 per 100,000 population (95% CI: 2.49\u20133.20) in 2000 to 6.27 per 100,000 population (95% CI: 5.83\u20136.73) in 2021. HSP incidence remained stable from 0.12 per 100,000 person-years (95% CI: 0.06\u20130.22) in 2000 to 0.29 per 100,000 person-years (95% CI: 0.20\u20130.40) in 2021. HSP patients had higher odds of baseline pre-existing depression (aOR: 1.74, 95% CI: 1.47\u20132.06) and anxiety (aOR: 1.31, 95% CI: 1.08\u20131.60); and higher hazard for new diagnosis of depression (adjusted hazard ratio [aHR]: 1.57, 95% CI: 1.26\u20131.96) and anxiety (aHR: 1.41, 95% CI: 1.12\u20131.76).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This first descriptive epidemiological study for HSP in England and Northern Ireland, demonstrated the utility of primary care routine health records for studying rare diseases. The higher rates of common mental health conditions in HSP patients illustrated the importance of access to mental health support.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03849-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:01:59Z","timestamp":1751367719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The epidemiology of hereditary spastic paraplegia and associated common mental health outcomes in England and Northern Ireland"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8681-8003","authenticated-orcid":false,"given":"Harini","family":"Jeyakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-5141","authenticated-orcid":false,"given":"Joht Singh","family":"Chandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6816-1279","authenticated-orcid":false,"given":"Krishnarajah","family":"Nirantharakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2332-5452","authenticated-orcid":false,"given":"Siang Ing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"12","key":"3849_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/S1474-4422(19)30235-2","volume":"18","author":"S Shribman","year":"2019","unstructured":"Shribman S, Reid E, Crosby AH, Houlden H, Warner TT. Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches. Lancet Neurol. 2019;18(12):1136\u201346.","journal-title":"Lancet Neurol"},{"issue":"6","key":"3849_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.31083\/j.jin2306115","volume":"23","author":"P Pavone","year":"2024","unstructured":"Pavone P, Falsaperla R, Polizzi A. A hundred faces for a unique disorder: hereditary spastic paraplegia. J Integr Neurosci. 2024;23(6):115.","journal-title":"J Integr Neurosci"},{"key":"3849_CR3","unstructured":"Hedera P. Hereditary Spastic Paraplegia Overview. 2000 (Updated 2021 Feb 11) [cited 27.12.2024]. In: GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle, [cited 27.12.2024]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1509\/."},{"issue":"8334","key":"3849_CR4","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","volume":"1","author":"AE Harding","year":"1983","unstructured":"Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet. 1983;1(8334):1151\u20135.","journal-title":"Lancet"},{"issue":"1","key":"3849_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12883-022-02595-4","volume":"22","author":"G Vander Stichele","year":"2022","unstructured":"Vander Stichele G, Durr A, Yoon G, Sch\u00fcle R, Blackstone C, Esposito G, et al. An integrated modelling methodology for estimating global incidence and prevalence of hereditary spastic paraplegia subtypes SPG4, SPG7, SPG11, and SPG15. BMC Neurol. 2022;22(1):115.","journal-title":"BMC Neurol"},{"key":"3849_CR6","unstructured":"Ortega Suero G, Abenza Abild\u00faa MJ, Serrano Munuera C, Rouco Axpe I, Arpa Guti\u00e9rrez FJ, Adarmes G\u00f3mez AD, et al. Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study. Neurologia (Engl Ed). 2021."},{"issue":"1","key":"3849_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/jnnp.72.1.43","volume":"72","author":"P McMonagle","year":"2002","unstructured":"McMonagle P, Webb S, Hutchinson M. The prevalence of \u201cpure\u201d autosomal dominant hereditary spastic paraparesis in the island of Ireland. J Neurol Neurosurg Psychiatry. 2002;72(1):43.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3849_CR8","unstructured":"Care DoHaS. The UK Rare Diseases Framework 2021 [Available from: https:\/\/www.gov.uk\/government\/publications\/uk-rare-diseases-framework."},{"issue":"Pt 6","key":"3849_CR9","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/brain\/awp056","volume":"132","author":"AK Erichsen","year":"2009","unstructured":"Erichsen AK, Koht J, Stray-Pedersen A, Abdelnoor M, Tallaksen CM. Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. Brain. 2009;132(Pt 6):1577\u201388.","journal-title":"Brain"},{"key":"3849_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.690899","volume":"8","author":"LEO Elsayed","year":"2021","unstructured":"Elsayed LEO, Eltazi IZ, Ahmed AE, Stevanin G. Insights into clinical, genetic, and pathological aspects of hereditary spastic paraplegias: a comprehensive overview. Front Mol Biosci. 2021;8: 690899.","journal-title":"Front Mol Biosci"},{"issue":"6","key":"3849_CR11","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ije\/dyz034","volume":"48","author":"A Wolf","year":"2019","unstructured":"Wolf A, Dedman D, Campbell J, Booth H, Lunn D, Chapman J, et al. Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum. Int J Epidemiol. 2019;48(6):1740.","journal-title":"Int J Epidemiol"},{"key":"3849_CR12","unstructured":"NHS. NHS Services: NHS UK; 2025 [Available from: https:\/\/www.nhs.uk\/nhs-services\/."},{"issue":"1","key":"3849_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s12913-022-08060-9","volume":"22","author":"R Spencer-Tansley","year":"2022","unstructured":"Spencer-Tansley R, Meade N, Ali F, Simpson A, Hunter A. Mental health care for rare disease in the UK \u2013 recommendations from a quantitative survey and multi-stakeholder workshop. BMC Health Serv Res. 2022;22(1):648.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"3849_CR14","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3390\/ijms23031697","volume":"23","author":"A Meyyazhagan","year":"2022","unstructured":"Meyyazhagan A, Orlacchio A. Hereditary spastic paraplegia: an update. Int J Mol Sci. 2022;23(3):1697.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3849_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.24611","volume":"79","author":"R Sch\u00fcle","year":"2016","unstructured":"Sch\u00fcle R, Wiethoff S, Martus P, Karle KN, Otto S, Klebe S, et al. Hereditary spastic paraplegia: clinicogenetic lessons from 608 patients. Ann Neurol. 2016;79(4):646\u201358.","journal-title":"Ann Neurol"},{"issue":"26","key":"3849_CR16","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1080\/09638288.2019.1610084","volume":"42","author":"H Kerstens","year":"2020","unstructured":"Kerstens H, Satink T, Nijkrake MJ, De Swart BJM, Van Lith BJH, Geurts ACH, et al. Stumbling, struggling, and shame due to spasticity: a qualitative study of adult persons with hereditary spastic paraplegia. Disabil Rehabil. 2020;42(26):3744\u201351.","journal-title":"Disabil Rehabil"},{"issue":"2","key":"3849_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/sc.2010.61","volume":"49","author":"M Braschinsky","year":"2011","unstructured":"Braschinsky M, Rannikm\u00e4e K, Krikmann U, L\u00fc\u00fcs SM, Raidvee A, Gross-Paju K, et al. Health-related quality of life in patients with hereditary spastic paraplegia in Estonia. Spinal Cord. 2011;49(2):175\u201381.","journal-title":"Spinal Cord"},{"issue":"9","key":"3849_CR18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1177\/0269215509337186","volume":"23","author":"L Vahter","year":"2009","unstructured":"Vahter L, Braschinsky M, Haldre S, Gross-Paju K. The prevalence of depression in hereditary spastic paraplegia. Clin Rehabil. 2009;23(9):857\u201361.","journal-title":"Clin Rehabil"},{"issue":"2","key":"3849_CR19","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/ene.12839","volume":"23","author":"KR Servelhere","year":"2016","unstructured":"Servelhere KR, Faber I, Saute JA, Moscovich M, D\u2019Abreu A, Jardim LB, et al. Non-motor symptoms in patients with hereditary spastic paraplegia caused by SPG4 mutations. Eur J Neurol. 2016;23(2):408\u201311.","journal-title":"Eur J Neurol"},{"key":"3849_CR20","unstructured":"Datalink CPR. CPRD Aurum December 2023 Dataset 2023 [Available from: https:\/\/www.cprd.com\/doi\/cprd-aurum-december-2023-dataset."},{"issue":"2","key":"3849_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10654-020-00677-6","volume":"36","author":"KM Gokhale","year":"2021","unstructured":"Gokhale KM, Chandan JS, Toulis K, Gkoutos G, Tino P, Nirantharakumar K. Data extraction for epidemiological research (DExtER): a novel tool for automated clinical epidemiology studies. Eur J Epidemiol. 2021;36(2):165\u201378.","journal-title":"Eur J Epidemiol"},{"key":"3849_CR22","unstructured":"Organisation WH. A Healthy Lifestyle- WHO Recommendations 2025 [Available from: https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/a-healthy-lifestyle---who-recommendations."},{"key":"3849_CR23","unstructured":"Government DoCaL. English Indices of Deprivation 2019 2019 [Available from: https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2019."},{"key":"3849_CR24","unstructured":"Digital N. Adult Psychiatric Morbidity Survey: Survey of Mental Health and Wellbeing, England, 2014 2014 [Available from: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/adult-psychiatric-morbidity-survey\/adult-psychiatric-morbidity-survey-survey-of-mental-health-and-wellbeing-england-2014."},{"key":"3849_CR25","unstructured":"Group H. HSP Group Website 2024 [Available from: https:\/\/hspgroup.org\/."},{"key":"3849_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pediatrneurol.2023.12.020","volume":"152","author":"BM Marvel","year":"2024","unstructured":"Marvel BM, Smith L, Rios JJ, Christie MR. A retrospective, cross-sectional analysis of motor development, cognition, and mood in 87 patients with childhood-onset hereditary spastic paraplegias. Pediatr Neurol. 2024;152:93\u20137.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"3849_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00415-019-09573-w","volume":"267","author":"TW Rattay","year":"2020","unstructured":"Rattay TW, Boldt A, V\u00f6lker M, Wiethoff S, Hengel H, Sch\u00fcle R, et al. Non-motor symptoms are relevant and possibly treatable in hereditary spastic paraplegia type 4 (SPG4). J Neurol. 2020;267(2):369\u201379.","journal-title":"J Neurol"},{"issue":"16_supplement","key":"3849_CR28","doi-asserted-by":"publisher","first-page":"S54.008","DOI":"10.1212\/WNL.88.16_supplement.S54.008","volume":"88","author":"V Chelban","year":"2017","unstructured":"Chelban V, Tucci A, Houlden H, Wood N. Development of the UK Hereditary Spastic Paraplegia registry: analysis of SPAST patients reveals high rate of psychiatric comorbidities (S54.008). Neurology. 2017;88(16_supplement):S54.008.","journal-title":"Neurology"},{"issue":"1","key":"3849_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1468-1331.2011.03443.x","volume":"19","author":"S Klimpe","year":"2012","unstructured":"Klimpe S, Sch\u00fcle R, Kassubek J, Otto S, Kohl Z, Klebe S, et al. Disease severity affects quality of life of hereditary spastic paraplegia patients. Eur J Neurol. 2012;19(1):168\u201371.","journal-title":"Eur J Neurol"},{"issue":"6","key":"3849_CR30","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s00415-019-09633-1","volume":"268","author":"M Erfanian Omidvar","year":"2021","unstructured":"Erfanian Omidvar M, Torkamandi S, Rezaei S, Alipoor B, Omrani MD, Darvish H, et al. Genotype-phenotype associations in hereditary spastic paraplegia: a systematic review and meta-analysis on 13,570 patients. J Neurol. 2021;268(6):2065\u201382.","journal-title":"J Neurol"},{"issue":"12","key":"3849_CR31","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1093\/brain\/awy285","volume":"141","author":"L Parodi","year":"2018","unstructured":"Parodi L, Fenu S, Barbier M, Banneau G, Duyckaerts C, Tezenas du Montcel S, et al. Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex. Brain. 2018;141(12):3331\u201342.","journal-title":"Brain"},{"issue":"1","key":"3849_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13023-022-02358-x","volume":"17","author":"A Bauskis","year":"2022","unstructured":"Bauskis A, Strange C, Molster C, Fisher C. The diagnostic odyssey: insights from parents of children living with an undiagnosed condition. Orphanet J Rare Dis. 2022;17(1):233.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"3849_CR33","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3109\/09638288.2013.824032","volume":"36","author":"J Grose","year":"2014","unstructured":"Grose J, Freeman J, Marsden J. Service delivery for people with hereditary spastic paraparesis living in the South West of England. Disabil Rehabil. 2014;36(11):907\u201313.","journal-title":"Disabil Rehabil"},{"issue":"4","key":"3849_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11910-021-01099-x","volume":"21","author":"L Saputra","year":"2021","unstructured":"Saputra L, Kumar KR. Challenges and controversies in the genetic diagnosis of hereditary spastic paraplegia. Curr Neurol Neurosci Rep. 2021;21(4):15.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3849_CR35","first-page":"189","volume":"152","author":"MA Kilic","year":"2024","unstructured":"Kilic MA, Yildiz EP, Deniz A, Coskun O, Kurekci F, Avci R, et al. A retrospective review of 18 patients with childhood-onset hereditary spastic paraplegia. Nine With Novel Variants Pediatr Neurol. 2024;152:189\u201395.","journal-title":"Nine With Novel Variants Pediatr Neurol"},{"key":"3849_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jbi.2016.08.005","volume":"63","author":"SC Bagley","year":"2016","unstructured":"Bagley SC, Altman RB. Computing disease incidence, prevalence and comorbidity from electronic medical records. J Biomed Inform. 2016;63:108\u201311.","journal-title":"J Biomed Inform"},{"key":"3849_CR37","unstructured":"Morris L RR. Tackling health inequalities: seven priorities for the NHS: The King\u2019s Fund; 2024 [Available from: https:\/\/www.kingsfund.org.uk\/insight-and-analysis\/long-reads\/tackling-health-inequalities-seven-priorities-nhs."},{"key":"3849_CR38","unstructured":"Care DoHaS. England Rare Diseases Action Plan 2024: Main Report. United Kingdom.: Department of Health and Social Care.; 2024."},{"issue":"3","key":"3849_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000358801","volume":"42","author":"L Ruano","year":"2014","unstructured":"Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 2014;42(3):174\u201383.","journal-title":"Neuroepidemiology"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03849-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03849-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03849-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:02:05Z","timestamp":1751367725000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03849-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3849"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03849-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CPRD has ethics approval from the Health Research Authority to support research using anonymised patient data. The study has been approved by the Independent Scientific Advisory Committee for CPRD (Reference #23_002705).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. Anonymised data is used in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Siang Ing Lee is a member of the research committee of the UK HSP Support Group.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"326"}}